Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249847 · ClinicalTrials.gov registry record · NA
Study of PET Scans and Serotonin in Hot Flashes Treatment
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00249847 is a NA study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 5 participants.
The verdict
NCT00249847, a NA study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine in a preliminary manner whether successful therapy of hot flashes can be associated with changes in the serotonin transporter in the brain. The serotonin transporter is important in delivering serotonin into certain portions of the brains (serotonin is a chemical that is important in the control of body temperature, mood, sleep, and other functions).
Interventions
- DRUG Paroxetine controlled-release
- DRUG Conjugated equine estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00249847
The ClinicalTrials.gov registry entry for NCT00249847 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paroxetine controlled-release is the first listed.
NCT00249847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00249847 about?
NCT00249847 is a clinical study titled "Study of PET Scans and Serotonin in Hot Flashes Treatment". The purpose of this study is to determine in a preliminary manner whether successful therapy of hot flashes can be associated with changes in the serotonin transporter in the brain. The serotonin transporter is important in delivering serotonin into certain portions of the brains (serotonin is a che...
What is the current status of trial NCT00249847?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2005-10. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00249847?
The interventions under investigation include: Paroxetine controlled-release (DRUG), Conjugated equine estrogen (DRUG).
Who is sponsoring clinical trial NCT00249847?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.